Details of the Drug

General Information of Drug (ID: DMAO7WM)

Drug Name
CYT-500
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 1 [1]
Cross-matching ID
TTD ID
D0A4VJ

References

1 ClinicalTrials.gov (NCT00441571) Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer. U.S. National Institutes of Health.